What is a stock summary page? Click here for an overview.
Business Description
Replimune Group Inc
NAICS : 325412
SIC : 2834
ISIN : US76029N1063
Compare
Compare
Traded in other countries / regions
REPL.USA7R8.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2018-07-20Description
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.06 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -23.5 | |||||
| 3-Year EPS without NRI Growth Rate | -27.1 | |||||
| 3-Year FCF Growth Rate | -27.7 | |||||
| 3-Year Book Growth Rate | -17.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 14.82 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.13 | |||||
| 9-Day RSI | 15.76 | |||||
| 14-Day RSI | 21.21 | |||||
| 3-1 Month Momentum % | -3.96 | |||||
| 6-1 Month Momentum % | 3.68 | |||||
| 12-1 Month Momentum % | 71.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.43 | |||||
| Quick Ratio | 11.43 | |||||
| Cash Ratio | 11.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.7 | |||||
| Shareholder Yield % | -43.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -54.7 | |||||
| ROA % | -42.94 | |||||
| ROIC % | -321.67 | |||||
| 3-Year ROIIC % | -1977.55 | |||||
| ROC (Joel Greenblatt) % | -417.74 | |||||
| ROCE % | -44.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.17 | |||||
| Price-to-Tangible-Book | 1.17 | |||||
| EV-to-EBIT | -0.66 | |||||
| EV-to-EBITDA | -0.67 | |||||
| EV-to-Forward-Revenue | 12.55 | |||||
| EV-to-FCF | -1.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.33 | |||||
| Price-to-Net-Cash | 1.36 | |||||
| Earnings Yield (Greenblatt) % | -151.52 | |||||
| FCF Yield % | -34.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:REPL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Replimune Group Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.07 | ||
| Beta | 0.59 | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.18 | ||
| Volatility % | 89.15 | ||
| 14-Day RSI | 21.21 | ||
| 14-Day ATR ($) | 0.785375 | ||
| 20-Day SMA ($) | 10.72425 | ||
| 12-1 Month Momentum % | 71.67 | ||
| 52-Week Range ($) | 4.92 - 17 | ||
| Shares Outstanding (Mil) | 77.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Replimune Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Replimune Group Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Replimune Group Inc Frequently Asked Questions
What is Replimune Group Inc(REPL)'s stock price today?
The current price of REPL is $7.33. The 52 week high of REPL is $17.00 and 52 week low is $4.92.
When is next earnings date of Replimune Group Inc(REPL)?
The next earnings date of Replimune Group Inc(REPL) is 2025-05-16 Est..
Does Replimune Group Inc(REPL) pay dividends? If so, how much?
Replimune Group Inc(REPL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers